Related Experiment Video
Updated: May 1, 2026

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data
Published on: June 26, 2013
Combined diagnostic value of NT-proBNP, DLK-1, PSP-D and PCSK-9 in heart failure with preserved ejection fraction: a
Liu Xiaobin1, Qin Yu1, Feng Jingjie2
1The First Hospital of Tsinghua University, Beijing, China.
Background:
Heart failure with preserved ejection fraction (HFpEF) remains a formidable clinical challenge due to its intricate pathophysiology and the difficulty in early diagnosis. Traditional biomarkers for HFpEF are often insufficient in clinical practice, driving the need for more novel, sensitive diagnostic markers.
Methods:
Serum samples from 58 HFpEF patients and 30 healthy controls were analyzed using Olink proteomics technology. Advanced machine-learning algorithms were employed to comprehensively compare the diagnostic performance of individual biomarkers and their combinations.
Results:
The serum levels of DLK-1, PSP-D, and PCSK-9 in HFpEF patients were higher than those in the control group. NT-proBNP, UA and PCSK-9 were identified as risk factors for HFpEF, with regression coefficients of 0.009 for NT-proBNP, 0.006 for UA, and 1.061 for PCSK-9 respectively. The area under the receiver operating characteristic curve (AUC) of the combination of NT-proBNP, DLK-1, PSP-D and PCSK-9 for the diagnosis of HFpEF reached 0.794. This value outperformed the AUC of the combination of PCSK-9 and NT-proBNP, 0.788, the combination of three markers (DLK-1, PSP-D, and PCSK-9, 0.622), as well as the AUCs of each of the four markers alone (NT-proBNP: 0.778, DLK-1: 0.578, PSP-D: 0.523, PCSK-9: 0.628).
Conclusion:
The combined detection of NT-proBNP, DLK-1, PSP-D and PCSK-9 can significantly enhance the specificity and sensitivity of the clinical diagnosis of HFpEF patients, holding great potential for improving the diagnostic accuracy of HFpEF in clinical settings.
Related Concept Videos
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Acute Coronary Syndrome III: Diagnostic Studies
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Sensitivity, Specificity, and Predicted Value
Sensitivity is the...
Cardiomyopathy II: Dilated Cardiomyopathy

